Metabolon, Inc. is the leader in high-throughput metabolomics technology since 2000. Metabolon operates its metabolomic technology platform in state-of-the-art laboratory facilities, with headquarters located in Durham, NC. Metabolon has advanced the field of metabolomics by pioneering and patenting the industry’s leading high throughput metabolomics platform. With over 90 patents covering processes and metabolomics methods (analytical and informatics), Metabolon has developed the technology to quickly identify and measure most of the metabolites in a biological sample. Our unique informatics systems, refined methods and extensive chemical reference library of more than 5,200 known and 8,000 novel metabolites produce the highest and most precise coverage (to our knowledge and reported in the public domain) of any metabolomics platform. Metabolon also has unique lipidomics capabilities with (to our knowledge) the only complex lipid platform that delivers complete and quantitative coverage of all the major classes of complex lipids.
MET PERSONNEL WORKING ON SOPHIA
Third-I 3i bvba
Third-i bvba is an innovative SME focussing on participatory, quadruple helix policy stakeholder engagement in the transformation of health ecosystems into person driven models. We have expertise in value-based healthcare (and related value-based procurement), multi-stakeholder engagement for establishing policy pathways which can be transformed into sustainable practices. We have hands on experience of Scoping the value of innovation (and link to video) in cancer care in patient centric multi-stakeholder environments.
Third-I PERSONNEL WORKING ON SOPHIA
Atturos is a young and innovative University College Dublin (UCD) spin-out company (December 2016) focussed on developing advanced multiplexed blood protein biomarker solutions to improve patient outcomes and have a global impact. Atturos’expertise and protein biomarker platform supports the development and implementation of analytically validated multiplexed protein biomarker assays to meet significant unmet clinical needs in chronic diseases. Atturos has a portfolio of in-house and licence-pending protein biomarker tests in development (clinical validation). The value of the platform has been identified by a number of blue-chip pharma companies who are working with Atturos to apply the platform (and assays) to their clinical translational efforts.
ATT PERSONNEL WORKING ON SOPHIA
Prof. Stephen Pennington
Drawing on many years of cutting-edge research experience, Lipotype delivers comprehensive, absolutely quantitative lipid analysis services for clinical and biological samples on a high-throughput scale. Lipotype offers high quality lipid analysis services for a wide range of customers and applications, including biomarker identification for clinical researchers, pharma and biotech companies, functional food development for the food industry, and also for the small-scale profiling needs of academic researchers. Lipotype is GMP certified.
LIPO PERSONNEL WORKING ON SOPHIA